Skip to content
Nandrolone cyclotate
Deca-durabolin (nandrolone cyclotate) is a small molecule pharmaceutical. Nandrolone cyclotate was first approved as Nandrolone decanoate on 1983-09-28.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nandrolone decanoate
Tradename
Company
Number
Date
Products
DECA-DURABOLINWOODWARD SPECLN-013132 DISCN1986-06-12
3 products, RLD
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
69 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Postoperative painD010149G89.18125513
PainD010146EFO_0003843R521236
PruritusD011537HP_0000989L294416
AnesthesiaD000758134
Healthy volunteers/patients1124
Postoperative nausea and vomitingD020250EFO_00048881113
AnalgesiaD000698112
Cesarean sectionD00258511
Injection site reactionD00007566211
Patient satisfactionD01706011
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PrurigoD011536L28.2333
Sickle cell anemiaD000755EFO_0000697D5711
Myeloid leukemia acuteD015470C92.011
T-cell leukemiaD01545811
Cleft palateD002972Q3511
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Emergence deliriumD000071257212
Labor painD048949112
Rotator cuff injuriesD000070636M75.111
Conscious sedationD01629211
Postoperative complicationsD01118311
Epidural anesthesiaD00076711
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Opioid-related disordersD009293EFO_0005611F1111
Hepatic insufficiencyD04855011
PharmacokineticsD01059911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Morbid obesityD009767EFO_000107411
Visceral painD05926511
Burning mouth syndromeD002054EFO_100085011
Temporomandibular joint dysfunction syndromeD01370611
Peritoneal dialysisD01053011
Obstructive sleep apneaD020181EFO_0003918G47.3311
Abdominal obesityD056128HP_000195611
Acute painD059787R5211
Inguinal herniaD006552HP_0000023K4011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNANDROLONE CYCLOTATE
INN
Description
Nandrolone cyclotate is a steroid ester.
Classification
Small molecule
Drug classandrogens; steroids (not prednisolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC12C=CC(C(=O)O[C@H]3CC[C@H]4[C@@H]5CCC6=CC(=O)CC[C@@H]6[C@H]5CC[C@]34C)(CC1)CC2
Identifiers
PDB
CAS-ID22263-51-0
RxCUI
ChEMBL IDCHEMBL2104906
ChEBI ID
PubChem CID164526
DrugBank
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 39 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
557 adverse events reported
View more details